Ipsen Biopharmaceuticals
MA · 14 filings, 2025
Lobbying spend · 2025
$320K
to shape legislation
About the organization
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. via Wikipedia ↗
1Lobbies on
Its filings list: Medicare/Medicaid · Taxation/Internal Revenue Code · Pharmacy
2Through these firms · 4
HOLLAND & KNIGHT LLPW STRATEGIES, LLCCAPITOL COUNSEL LLCRICCHETTI INCORPORATED
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5236A bill to amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services…
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5227A bill to amend the Internal Revenue Code of 1986 to allow certain distributions from long-term qualified t…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…